Immunotherapy in the Management of Penile Cancer—A Systematic Review.
Recent Publication
In a recent review, OA PD Dr Hossein Taghizadeh and Prim. Assoc. Prof. PD Dr Harun Fajkovic from St. Pölten University Hospital shed light on the use of immunotherapy for penile cancer - a rare cancer for which there are currently only limited treatment options, especially in advanced stages. They show that modern immunotherapies, so-called checkpoint inhibitors, can be effective in some patient groups - especially if certain biological characteristics such as HPV infection or PD-L1 expression are present. Combinations with existing therapies such as chemotherapy or radiotherapy could also open up new avenues in the future.
Taghizadeh, H., & Fajkovic, H. (2025). Immunotherapy in the Management of Penile Cancer—A Systematic Review. Cancers, 17(5), 883. https://doi.org/10.3390/cancers17050883
OA PD Dr. Hossein Taghizadeh MSc PhD
Division of Internal Medicine 1 (University Hospital St. Pölten)
Prim. Univ.-Prof. PD Dr. Harun Fajkovic MSc FEBU
Division of Urology and Andrology (University Hospital St. Pölten)